Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer
Open Access
- 1 July 1991
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 64 (1) , 79-83
- https://doi.org/10.1038/bjc.1991.243
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesBritish Journal of Cancer, 1991
- Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.1991
- GENE AMPLIFICATION IN GASTRIC AND ESOPHAGEAL ADENOCARCINOMAS1990
- The c‐erbB‐2 proto‐oncogene in human pancreatic cancerThe Journal of Pathology, 1990
- ABSENCE OF ACTIVATING TRANSMEMBRANE MUTATIONS IN THE C-ERBB-2 PROTOONCOGENE IN HUMAN BREAST-CANCER1990
- Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.1988
- Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.Molecular and Cellular Biology, 1986
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984
- A monoclonal antibody to the human epidermal growth factor receptorJournal of Cellular Biochemistry, 1982
- Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probesCell, 1980